Wang S, Oliveira-Silveira J, Fang G, Kang J
BMC Cancer. 2024; 24(1):335.
PMID: 38475728
PMC: 11542337.
DOI: 10.1186/s12885-024-12057-4.
Pan Y, Ren H, Lan L, Li Y, Huang T
Life (Basel). 2023; 13(9).
PMID: 37763281
PMC: 10533134.
DOI: 10.3390/life13091878.
Jiang J, Chen S, Tsou T, McGinnis C, Khazaei T, Zhu Q
bioRxiv. 2023; .
PMID: 37131803
PMC: 10153191.
DOI: 10.1101/2023.04.19.537364.
Wu L, Gao J, Zhang Y, Sui B, Wen Y, Wu Q
Cell Rep Methods. 2023; 3(2):100411.
PMID: 36936075
PMC: 10014304.
DOI: 10.1016/j.crmeth.2023.100411.
Lyons M
Antimicrob Agents Chemother. 2022; 66(12):e0089822.
PMID: 36377952
PMC: 9765268.
DOI: 10.1128/aac.00898-22.
PINet 1.0: A pathway network-based evaluation of drug combinations for the management of specific diseases.
Hong Y, Chen D, Jin Y, Zu M, Zhang Y
Front Mol Biosci. 2022; 9:971768.
PMID: 36330216
PMC: 9623281.
DOI: 10.3389/fmolb.2022.971768.
Mathematical Modelling of the Molecular Mechanisms of Interaction of Tenofovir with Emtricitabine against HIV.
Iannuzzi S, von Kleist M
Viruses. 2021; 13(7).
PMID: 34372560
PMC: 8310192.
DOI: 10.3390/v13071354.
Automatic identification of small molecules that promote cell conversion and reprogramming.
Napolitano F, Rapakoulia T, Annunziata P, Hasegawa A, Cardon M, Napolitano S
Stem Cell Reports. 2021; 16(5):1381-1390.
PMID: 33891873
PMC: 8185468.
DOI: 10.1016/j.stemcr.2021.03.028.
Gene regulation gravitates toward either addition or multiplication when combining the effects of two signals.
Sanford E, Emert B, Cote A, Raj A
Elife. 2020; 9.
PMID: 33284110
PMC: 7771960.
DOI: 10.7554/eLife.59388.
Transcriptomic Signatures Predict Regulators of Drug Synergy and Clinical Regimen Efficacy against Tuberculosis.
Ma S, Jaipalli S, Larkins-Ford J, Lohmiller J, Aldridge B, Sherman D
mBio. 2019; 10(6).
PMID: 31719182
PMC: 6851285.
DOI: 10.1128/mBio.02627-19.
Drug Combinations: Mathematical Modeling and Networking Methods.
Vakil V, Trappe W
Pharmaceutics. 2019; 11(5).
PMID: 31052580
PMC: 6571786.
DOI: 10.3390/pharmaceutics11050208.
Chemogenomic model identifies synergistic drug combinations robust to the pathogen microenvironment.
Cokol M, Li C, Chandrasekaran S
PLoS Comput Biol. 2019; 14(12):e1006677.
PMID: 30596642
PMC: 6329523.
DOI: 10.1371/journal.pcbi.1006677.
Combinatorial processing of bacterial and host-derived innate immune stimuli at the single-cell level.
Gutschow M, Mason J, Lane K, Maayan I, Hughey J, Bajar B
Mol Biol Cell. 2018; 30(2):282-292.
PMID: 30462580
PMC: 6589564.
DOI: 10.1091/mbc.E18-07-0423.
Low-dose chemotherapeutic drugs induce reactive oxygen species and initiate apoptosis-mediated genomic instability.
Arun R, Dhivya S, Abraham S, Premkumar K
Toxicol Res (Camb). 2018; 5(2):547-556.
PMID: 30090369
PMC: 6062221.
DOI: 10.1039/c5tx00391a.
Multi-Scale Network Model Supported by Proteomics for Analysis of Combined Gemcitabine and Birinapant Effects in Pancreatic Cancer Cells.
Zhu X, Shen X, Qu J, Straubinger R, Jusko W
CPT Pharmacometrics Syst Pharmacol. 2018; 7(9):549-561.
PMID: 30084546
PMC: 6157671.
DOI: 10.1002/psp4.12320.
Prediction of drug cocktail effects when the number of measurements is limited.
Zimmer A, Tendler A, Katzir I, Mayo A, Alon U
PLoS Biol. 2017; 15(10):e2002518.
PMID: 29073201
PMC: 5675459.
DOI: 10.1371/journal.pbio.2002518.
An Endogenously Tagged Fluorescent Fusion Protein Library in Mouse Embryonic Stem Cells.
Harikumar A, Edupuganti R, Sorek M, Azad G, Markoulaki S, Sehnalova P
Stem Cell Reports. 2017; 9(4):1304-1314.
PMID: 28966122
PMC: 5639459.
DOI: 10.1016/j.stemcr.2017.08.022.
Genome-scale regression analysis reveals a linear relationship for promoters and enhancers after combinatorial drug treatment.
Rapakoulia T, Gao X, Huang Y, de Hoon M, Okada-Hatakeyama M, Suzuki H
Bioinformatics. 2017; 33(23):3696-3700.
PMID: 28961713
PMC: 5860321.
DOI: 10.1093/bioinformatics/btx503.
Dynamic proteomics reveals bimodal protein dynamics of cancer cells in response to HSP90 inhibitor.
Zimmer A, Amar-Farkash S, Danon T, Alon U
BMC Syst Biol. 2017; 11(1):33.
PMID: 28270142
PMC: 5341406.
DOI: 10.1186/s12918-017-0410-8.
Epigenetic polypharmacology: from combination therapy to multitargeted drugs.
de Lera A, Ganesan A
Clin Epigenetics. 2016; 8:105.
PMID: 27752293
PMC: 5062873.
DOI: 10.1186/s13148-016-0271-9.